Cargando…
Predicting Harms and Benefits in Translational Trials: Ethics, Evidence, and Uncertainty
Autores principales: | Kimmelman, Jonathan, London, Alex John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050916/ https://www.ncbi.nlm.nih.gov/pubmed/21423344 http://dx.doi.org/10.1371/journal.pmed.1001010 |
Ejemplares similares
-
Why clinical translation cannot succeed without failure
por: London, Alex John, et al.
Publicado: (2015) -
Business Versus Ethics? Thoughts on the Future of Business Ethics
por: Dacin, M. Tina, et al.
Publicado: (2022) -
Neuroscience, Ethics, and National Security: The State of the Art
por: Tennison, Michael N., et al.
Publicado: (2012) -
The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?
por: Carr, Andrew, et al.
Publicado: (2012) -
Communicating with Patients about Harms and Risks
por: Herxheimer, Andrew
Publicado: (2005)